Know Your Customer verification
Know Your Customer verification in Healthcare & Life Sciences sits at the intersection of anti-money laundering obligations and patient privacy law, a combination that draws scrutiny from the Financial Crimes Enforcement Network, the U.S. Department of Health and Human Services Office for Civil Rights, and the European Banking Authority simultaneously. Pharmaceutical distributors, specialty pharmacies, and health system treasury functions are increasingly required to reconcile KYC onboarding workflows with HIPAA minimum-necessary standards, creating friction that regulators have not yet resolved with unified guidance. FinCEN's beneficial ownership rule under the Corporate Transparency Act, now in enforcement posture for most covered entities, is the live pressure point compliance teams are working through right now.
Watch
- Corporate Transparency Act beneficial ownership filings: deadlines vary by entity formation date
- FinCEN's proposed rulemaking on investment advisers: watch for spillover into healthcare fund structures
- EBA's revised Anti-Money Laundering guidelines affecting EU-licensed pharmaceutical distributors
- HHS OCR enforcement pattern on third-party data access during KYC vendor onboarding
- State-level money transmitter licensing: several states now capturing healthcare payment processors
Recent material activity in Healthcare & Life Sciences
-
FDA issues Complete Response Letter for novel GLP-1 receptor agonist oral formulation
The FDA issued a CRL for a once-daily oral GLP-1 receptor agonist citing manufacturing consistency concerns at the primary production facility. The agency requested additional CMC data and a pre-approval inspection befor…
Read a full sample brief →